Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia : vimarsana.com

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Advanz Pharma , Shoshana Shendelman , Maeve Conneighton , Drug Administration , Health Index , Committee For Medicinal Products Human Use , European Medicines Agency , Therapeutics Inc , Nasdaq , Exchange Commission , Twitter , Action Date , New Drug Application , Classic Galactosemia , Prescription Drug User Fee Act , Applied Therapeutics , Major Amendment , Priority Review , Pediatric Rare Disease , Priority Review Voucher , Aldose Reductase Inhibitor , Galactosemia Kids , Applied Therapeutic , Marketing Authorization Application , Medicinal Products , Human Use , Orphan Medicinal Product Designation , Orphan Drug Designation , Fast Track , Diabetic Cardiomyopathy , Private Securities Litigation Reform Act ,